Fredun Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
2,571.00
42.15 (1.67%)
BSENSE

May 25

BSE+NSE Vol: 13.78 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002605,
    "name": "Fredun Pharma",
    "stock_name": "Fredun Pharma",
    "full_name": "Fredun Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/fredun-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,571.00",
    "chg": 42.15,
    "chgp": "1.67%",
    "dir": 1,
    "prev_price": "2,528.85",
    "mcapval": "1,417.31 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539730,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE194R01017",
    "curr_date": "May 25",
    "curr_time": "",
    "bse_nse_vol": "13.78 k",
    "exc_status": "Active",
    "traded_date": "May 25, 2026",
    "traded_date_str": "2026 05 25",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2620",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2620-4010559",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4010559.png",
        "date": "2026-05-25 10:48:41",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd touched a new 52-week high of Rs 2620 on 25 May 2026, marking a remarkable 253.81% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained earnings growth, setting the stage for a compelling price rally within the pharmaceuticals sector."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,620 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-all-time-high-at-rs-2620-mark-4010483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4010483.png",
        "date": "2026-05-25 10:29:42",
        "description": ""
      },
      {
        "title": "Fredun Pharmaceuticals Gains 6.86%: Four Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-gains-686-four-key-factors-driving-the-surge-4008259",
        "imagepath": "",
        "date": "2026-05-23 13:06:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock opens at Rs.2,302.55, down 2.70%</p>\n                    <p><strong>21 May:</strong> New 52-week and all-time high at Rs.2,560</p>\n                    <p><strong>22 May:</strong> Hits record high of Rs.2,619.95</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.2,528.85, up 6.86%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,366.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,528.85</div><div class=\"stat-change positive\">+6.86%</di..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2619.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-of-rs261995-4004666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4004666.png",
        "date": "2026-05-22 09:47:36",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd reached a new 52-week high of Rs 2619.95 on 22 May 2026, marking a remarkable rally that has seen the stock gain over 250% in the past year. This milestone reflects a powerful confluence of technical momentum and sustained price strength, setting the stage for further market attention."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,619.95 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-record-high-of-rs-261995-on-22-may-2026-4004612",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4004612.png",
        "date": "2026-05-22 09:33:51",
        "description": "Extending its winning streak to four consecutive sessions, Fredun Pharmaceuticals Ltd surged to a fresh all-time high of Rs 2,619.95 on 22 May 2026, outperforming its sector and the broader market with a 1.81% gain on the day against the Sensex’s 0.46% rise."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2560",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2560-4003335",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4003335.png",
        "date": "2026-05-21 15:10:48",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd reached a fresh 52-week high of Rs 2560 on 21 May 2026, marking a remarkable rally from its 52-week low of Rs 690. This milestone caps a sustained upward momentum driven by a confluence of robust technical indicators and strong price action over recent sessions."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,560 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-all-time-high-marking-a-significant-milestone-4003244",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4003244.png",
        "date": "2026-05-21 14:38:04",
        "description": ""
      },
      {
        "title": "Fredun Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3995245",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_mojoScore_3995245.png",
        "date": "2026-05-17 10:10:37",
        "description": "Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 17 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Dips 0.36% Despite All-Time High: 3 Key Factors Behind the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-dips-036-despite-all-time-high-3-key-factors-behind-the-weeks-volatility-3994328",
        "imagepath": "",
        "date": "2026-05-16 13:07:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 11:</strong> New 52-week high at Rs.2,550 and all-time high near Rs.2,548</p>\n                    <p><strong>May 12:</strong> Sharp correction of 6.34% amid broader market sell-off</p>\n                    <p><strong>May 14:</strong> Modest recovery with 1.32% gain supported by technical strength</p>\n                    <p><strong>May 15:</strong> Week closes at Rs.2,366.45, down 0.36% for the week but outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,374.95</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-l..."
      }
    ],
    "total": 271,
    "sid": "1002605",
    "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "15-May-2026",
      "details": "Fredun Pharmaceuticals Limited Unveils Cellular Longetivity Dedicated Platform Daulcel",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for The Meeting To Be Held On Monday 25 May 2026.",
      "datetime": "15-May-2026",
      "details": "Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve 1. Consider and approve Audited Financial Results & Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March 2026. 2. Consider and recommend final dividend on the paid-up equity shares for the Financial Year ended 31st March 2026. 3. Consider and recommend Bonus Equity Shares subject to approval of Members of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 15.05.2026",
      "datetime": "15-May-2026",
      "details": "The Board of Directors of the Company at their Board Meeting held on Friday May 15 2026 at 07:30 P.M through Video Conferencing (VC) inter alia transacted the following businesses: 1. Took note of the Monitoring Agency Report for the quarter ended March 31 2026. The Meeting of the Board of Directors Commenced at 07:30 P.M. and concluded at 08:00 P.M.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(25 May 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Sep 25",
          "dt": "2025-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Fredun Pharmaceuticals Gains 6.86%: Four Key Factors Driving the Surge

2026-05-23 13:06:03

Key Events This Week

18 May: Stock opens at Rs.2,302.55, down 2.70%

21 May: New 52-week and all-time high at Rs.2,560

22 May: Hits record high of Rs.2,619.95

22 May: Week closes at Rs.2,528.85, up 6.86%

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

15-May-2026 | Source : BSE

Fredun Pharmaceuticals Limited Unveils Cellular Longetivity Dedicated Platform Daulcel

Board Meeting Intimation for The Meeting To Be Held On Monday 25 May 2026.

15-May-2026 | Source : BSE

Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve 1. Consider and approve Audited Financial Results & Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March 2026. 2. Consider and recommend final dividend on the paid-up equity shares for the Financial Year ended 31st March 2026. 3. Consider and recommend Bonus Equity Shares subject to approval of Members of the Company.

Board Meeting Outcome for Outcome Of Board Meeting Dated 15.05.2026

15-May-2026 | Source : BSE

The Board of Directors of the Company at their Board Meeting held on Friday May 15 2026 at 07:30 P.M through Video Conferencing (VC) inter alia transacted the following businesses: 1. Took note of the Monitoring Agency Report for the quarter ended March 31 2026. The Meeting of the Board of Directors Commenced at 07:30 P.M. and concluded at 08:00 P.M.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(25 May 2026)

stock-summary
DIVIDEND

Fredun Pharmaceuticals Ltd has declared 7% dividend, ex-date: 23 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available